Kristina Masson - Feb 14, 2024 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
EVP - Business Operations, Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Feb 14, 2024
Transactions value $
-$1,969
Form type
4
Date filed
2/16/2024, 05:13 PM
Previous filing
Nov 16, 2023
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability -$1.97K -579 -0.18% $3.40 318K Feb 14, 2024 Direct F1
holding ACRV Common Stock 2.62M Feb 14, 2024 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
F2 These securities are held by President and CEO, Peter Blume-Jensen, who is also Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.